Skip to main content
. 1999 May;181(9):2914–2921. doi: 10.1128/jb.181.9.2914-2921.1999

TABLE 1.

Plasmids used in this study

Plasmid Relevant description Source or reference
pBluescript II SK(+) 3.0 kb; Apr; lacPOZ′; cloning vector Stratagene
pTV119N 3.2 kb; Apr; lacPOZ′; cloning vector Takara
pPDES3.6 6.6 kb; pBluescript II SK(+) carrying 3.6-kb fragment containing phaCPd 31
pPDH6.5 9.5 kb; pBluescript II SK(+) carrying 6.5-kb fragment containing phaABPd 32
pPDPP7.2 10.2 kb; pBluescript II SK(+) carrying 7.2-kb fragment containing pha′CPRPd This study
pPDPP2.6 5.6 kb; pBluescript II SK(+) carrying 2.6-kb fragment containing ORF1 This study
pPDPA4.5 7.4 kb; pBluescript II SK(+) carrying 4.5-kb fragment containing pha′CPRPd This study
pPDPX2.2 5.1 kb; pBluescript II SK(+) carrying 2.1-kb fragment containing pha′CPRPd This study
pPDPK1.7 4.6 kb; pBluescript II SK(+) carrying 1.7-kb fragment containing pha′CPR′Pd This study
pTVC 5.2 kb; pTV119N carrying 2.0-kb fragment containing phaCPd This study
pTVCP 5.7 kb; pTV119N carrying 2.6-kb fragment containing phaCPPd This study
pTVCP4 6.4 kb; pTV119N carrying 3.3-kb fragment containing phaCPRPd This study
pBBRKm 5.8 kb; Kmr Tra+ Mob+; broad-host-range cloning vector from pBBR1MCS (10); not belonging to InqP, InqQ, or InqW groups 31
pBBRKmAB 7.3 kb; pBBRKm derivative containing phaABPd This study